David M. Herrington, MD, MHS

Professor, Internal Medicine (Cardiology)
Associate in Public Health Sciences

Email: dherring@wfubmc.edu

Education:

Davidson College, BS, 1979
University of North Carolina-Chapel Hill School of Medicine, MD, 1983
The Johns Hopkins University School Hygiene and Public Health, MHS, 1989

Research Interests:

Dr. Herrington's focus is on the role of estrogen in the pathogenesis of coronary heart disease in postmenopausal women. Of late, he has investigated genetic approaches to understanding differential responses to estrogen agonists (hormone replacement therapy or selective estrogen receptor modulators), in collaboration with colleagues in the Human Genomics Center. This promising avenue is now a major area of Dr. Herrington's research activity, and he holds three R01 awards to pursue research questions in this area.

Publications:

Yeboah J, Sane DC, Crouse JR, Herrington DM, Bowden DW. Low plasma levels of FGF-2 and PDGF-BB are associated with cardiovascular events in type II diabetes mellitus (diabetes heart study). Dis Markers. 2007;23(3):173-8.

Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007 May 8;115(18):2390-7. Epub 2007 Apr 23.

Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: A meta-analysis. Nutr Metab Cardiovasc Dis. 2007 Apr 19.

Mellen PB, Bleyer AJ, Herrington DM. Response to Treatment of Hyperuricemia in Essential Hypertension.Hypertension. 2007 Apr 2.

Lakoski SG, Li L, Langefeld CD, Liu Y, Howard TD, Brosnihan KB, Xu J, Bowden DW, Herrington DM. The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study. Exp Mol Pathol. 2007 Jun;82(3):280-3. Epub 2007 Feb 22.

Publications:
For a listing of additional publications, refer to PubMed, a service provided by the National Library of Medicine